Recursion Pharmaceuticals (RXRX): A Promising Small-Cap in Biotech Innovation - MSN
3 hours ago • Google News
Recursion Pharmaceuticals Inc (RXRX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 2.11B
P/E Ratio
0.00
Revenue (TTM)
$ 64.6M
Volume
0
52W High
$ 12.36
52W Low
$ 3.79
Dividend Yield
0.00%
Beta
0.91
Technicals
50-Day MA
5.3438
200-Day MA
5.9919
52 Week High
12.36
52 Week Low
3.79
About RXRX
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, au.
Employees
800
Headquarters
Salt Lake City, UT
CEO
Dr. Christopher C. Gibson Ph.D.